Drug, co-invented by MEDGEN’S Dr Josef Penninger found to block COVID-19, cleared for STAGE 2 drug trial

April 4, 2020. Penninger et al. explain in a new study just published in the journal Cell that the cell membrane-surface protein ACE2 plays a key role in outbreak.

Story feature UBC News April 2, 2020.

CBC British Columbia.